For security purposes
FOR SECURITY PURPOSES - because Internet Explorer is no longer supported by Microsoft, we suggest that you interact with our secure site through one of our supported browsers - Google Chrome, Firefox, or MS Edge. If you continue to use this website with Internet Explorer you do so at your own risk and you may encounter problems.
Documents
Separation of Rivaroxaban and its Chiral Impurities per USP Monograph
In this application note, we report the separation of Rivaroxaban and its related chiral impurities using a Lux 5 µm i-Cellulose-5 column compared with a CHIRALPAK 5 µm IC column according to the USP monograph for Rivaroxaban, which specifies a column containing L119 (Cellulose tris-(3,5-dichlorophenylcarbamate)) packing with dimensions of 250 x 4.6 mm

Separation of Rivaroxaban and its Chiral Impurities per USP Monograph

In this application note, we report the separation of Rivaroxaban and its related chiral impurities using a Lux 5 µm i-Cellulose-5 column compared with a CHIRALPAK 5 µm IC column according to the USP monograph for Rivaroxaban, which specifies a column containing L119 (Cellulose tris-(3,5-dichlorophenylcarbamate)) packing with dimensions of 250 x 4.6 mm
Document Type:
Technical Notes
Target Industries:
Techniques:
Brands:
Separation Modes:
Chiral